|
|||||
|
|
The influence of baseline characteristics and disease stage on health‐related quality of life in multiple myeloma: findings from six randomized controlled trials |
|
| Authors: | Don Robinson Jr Dixie‐Lee Esseltine Antoine Regnault Juliette Meunier Kevin Liu Helgi van de Velde |
| Institution: | 1. Janssen Global Services, Raritan, NJ, USA;2. Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA;3. Mapi Patient‐Centred Outcomes, Lyon, France;4. Janssen Research & Development, Raritan, NJ, USA |
| Abstract: | |
| Keywords: | multiple myeloma quality of life EORTC QLQ‐C30 disease stages integrated analysis |